text
"['\nIX. 계열회사 등에 관한 사항\n타법인출자 현황\n(기준일 :\xa0\n2020년 06월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nTongyang Network Thailand Co., Ltd.(비상장)\n2013.07.01\n현지신규사업진출\n37\n-\n-\n-\n-\n-\n-\n-\n-\n-\n3\n-\nTongyang Thailand Co., Ltd.(비상장)\n2013.07.01\n현지신규사업진출\n74\n-\n-\n-\n-\n-\n-\n-\n-\n-\n16\n-\n(주)모아바(비상장)\n2000.08.25\n사업다각화 신규사업진출\n152\n30,400\n19\n152\n-\n-\n-\n30,400\n19\n152\n1,160\n46\n소프트웨어공제조합(비상장)\n1998.07.07\n이행보증 담보제공\n950\n2,505\n0.63\n1,726\n-2,505\n-1,762\n36\n-\n-\n-\n-\n-\nMEDIGENE AG(상장)\n2018.05.31\n해외 바이오사업진출 및 기업가치 증대\n30,955\n1,650,000\n6.72\n8,563\n-\n-\n2,465\n1,650,000\n6.72\n11,028\n141,699\n-26,047\nTY BIO INVESTMENT, INC.(비상장)\n2018.07.09\n해외 자회사 설립을 통해서 바이오기업 투자 진행\n3,346\n1,470\n49\n1,639\n-\n-\n-\n-\n49\n1,639\n12,787\n-755\n제이에이치W투자조합(비상장)\n2018.10.29\n단기자금 운용목적\n3,000\n3,000\n20\n2,108\n-\n-\n-685\n3,000\n20\n1,423\n15,000\n-53\n에이스우진(주)(비상장)(*)\n2019.04.22\n사업다각화 신규사업진출\n45,000\n327,249\n31.3\n43,800\n-\n-\n-\n327,249\n31.3\n43,800\n-\n-\n합 계\n2,014,624\n-\n57,988\n-2,505\n-1,762\n1,816\n2,010,649\n-\n58,042\n-\n-\n']"
